Since cathepsins are ubiquitous proteases and distributed in various tissues and organs, targeting them could cause corresponding side effects in different organs, such as lung fibrosis [80], morphea-like skin lesions [81,82], cardiovascular complications [83], etc. Therefore, targeting cathepsin presents significant challenges. The gene discussed is CTSS; the disease is pulmonary fibrosis.